- Home
- PRTA vs REFI Comparison
PRTA vs REFI Comparison
Compare PRTA & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- REFI
- Stock Information
- Founded
- PRTA 2012
- REFI 2021
- Country
- PRTA Ireland
- REFI United States
- Employees
- PRTA N/A
- REFI N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- REFI Real Estate Investment Trusts
- Sector
- PRTA Health Care
- REFI Real Estate
- Exchange
- PRTA Nasdaq
- REFI Nasdaq
- Market Cap
- PRTA 346.4M
- REFI 294.0M
- IPO Year
- PRTA N/A
- REFI 2021
- Fundamental
- Price
- PRTA $6.29
- REFI $13.29
- Analyst Decision
- PRTA Buy
- REFI Strong Buy
- Analyst Count
- PRTA 9
- REFI 3
- Target Price
- PRTA $27.67
- REFI $20.00
- AVG Volume (30 Days)
- PRTA 1.3M
- REFI 110.1K
- Earning Date
- PRTA 08-07-2025
- REFI 08-07-2025
- Dividend Yield
- PRTA N/A
- REFI 14.13%
- EPS Growth
- PRTA N/A
- REFI N/A
- EPS
- PRTA N/A
- REFI 1.88
- Revenue
- PRTA $137,935,000.00
- REFI $56,790,054.00
- Revenue This Year
- PRTA N/A
- REFI $16.46
- Revenue Next Year
- PRTA $122.02
- REFI $6.50
- P/E Ratio
- PRTA N/A
- REFI $7.08
- Revenue Growth
- PRTA 54.55
- REFI 4.68
- 52 Week Low
- PRTA $4.32
- REFI $12.76
- 52 Week High
- PRTA $25.42
- REFI $16.47
- Technical
- Relative Strength Index (RSI)
- PRTA 56.80
- REFI 32.08
- Support Level
- PRTA $6.16
- REFI $13.85
- Resistance Level
- PRTA $6.60
- REFI $13.87
- Average True Range (ATR)
- PRTA 0.27
- REFI 0.25
- MACD
- PRTA 0.04
- REFI -0.05
- Stochastic Oscillator
- PRTA 67.90
- REFI 1.02
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.